Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$7.58 -0.27 (-3.44%)
As of 03:16 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$7.25
$7.75
50-Day Range
$6.10
$7.85
52-Week Range
$4.66
$7.99
Volume
3,743 shs
Average Volume
15,200 shs
Market Capitalization
$124.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Buy

Company Overview

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
BioHarvest enters fragrance industry with AI edge - ICYMI
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the start of the year. Since then, BHST shares have increased by 25.4% and is now trading at $7.75.

BioHarvest Sciences Inc. (NASDAQ:BHST) announced its quarterly earnings results on Thursday, May, 15th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The company had revenue of $7.64 million for the quarter, compared to analysts' expectations of $8.93 million. BioHarvest Sciences had a negative trailing twelve-month return on equity of 307.04% and a negative net margin of 31.30%.
Read the conference call transcript
.

BioHarvest Sciences' top institutional shareholders include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
7/25/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
CIK
1723464
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+76.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.91 million
Net Margins
-31.30%
Pretax Margin
-31.13%
Return on Equity
-307.04%
Return on Assets
-33.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.51
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$25.19 million
Price / Sales
5.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
96.88

Miscellaneous

Outstanding Shares
16,420,000
Free Float
N/A
Market Cap
$127.26 million
Optionable
N/A
Beta
0.65
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners